湖北:按病种收付费年底前覆盖二级以上公立医院

2018-06-25 黎昌政 新华社

2018年底前,湖北按病种收付费将覆盖全省所有二级以上公立医院,通过“打包式”收费控制医疗费用,缓解“看病贵”难题。

2018年底前,湖北按病种收付费将覆盖全省所有二级以上公立医院,通过“打包式”收费控制医疗费用,缓解“看病贵”难题。

记者从湖北省卫生计生委获悉,湖北省物价局、卫计委、人社厅日前联合发出通知,在各地按病种收付费改革试点的基础上,扩大按病种收付费实施范围到所有二级以上公立医院,各地可根据实际选取更多数量的病种纳入按病种收付费管理

按病种收付费实行看病“一口价”:患者从入院就诊到康复出院,整个过程中发生的诊断、治疗、手术、麻醉、护理、床位、药品及医用耗材不再按项目单独计费,合并为按病种收付费标准。实际费用超出标准的由医疗机构承担,以此倒逼医疗机构合理检查、合理治疗、合理收费。

据湖北省卫生计生委有关负责人介绍,按病种收付费改革重点在临床路径规范、治疗效果明确的常见病和多发病领域开展。去年底以来,湖北在辖区内三级和部分二级公立医院实施了100个以上常见病、多发病按病种收付费改革,在规范诊疗行为、控制医药费用不合理增长等方面成效明显。相关部门还将进一步完善机制,调动医疗机构按病种收费的积极性和主动性。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1548310, encodeId=ed13154831066, content=<a href='/topic/show?id=e29a2536eb2' target=_blank style='color:#2F92EE;'>#付费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25367, encryptionId=e29a2536eb2, topicName=付费)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71414069159, createdName=ms4657536712156177, createdTime=Wed Jun 27 08:24:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327120, encodeId=b7f032e120d6, content=改革创新永远在路上, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Tue Jun 26 08:57:30 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326960, encodeId=373832696025, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Jun 25 19:04:41 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326943, encodeId=fc1832694317, content=好吧., beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Jun 25 18:29:02 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1548310, encodeId=ed13154831066, content=<a href='/topic/show?id=e29a2536eb2' target=_blank style='color:#2F92EE;'>#付费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25367, encryptionId=e29a2536eb2, topicName=付费)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71414069159, createdName=ms4657536712156177, createdTime=Wed Jun 27 08:24:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327120, encodeId=b7f032e120d6, content=改革创新永远在路上, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Tue Jun 26 08:57:30 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326960, encodeId=373832696025, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Jun 25 19:04:41 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326943, encodeId=fc1832694317, content=好吧., beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Jun 25 18:29:02 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-26 易水河

    改革创新永远在路上

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1548310, encodeId=ed13154831066, content=<a href='/topic/show?id=e29a2536eb2' target=_blank style='color:#2F92EE;'>#付费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25367, encryptionId=e29a2536eb2, topicName=付费)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71414069159, createdName=ms4657536712156177, createdTime=Wed Jun 27 08:24:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327120, encodeId=b7f032e120d6, content=改革创新永远在路上, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Tue Jun 26 08:57:30 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326960, encodeId=373832696025, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Jun 25 19:04:41 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326943, encodeId=fc1832694317, content=好吧., beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Jun 25 18:29:02 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-25 惠映实验室

    学习了.谢谢分享.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1548310, encodeId=ed13154831066, content=<a href='/topic/show?id=e29a2536eb2' target=_blank style='color:#2F92EE;'>#付费#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25367, encryptionId=e29a2536eb2, topicName=付费)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71414069159, createdName=ms4657536712156177, createdTime=Wed Jun 27 08:24:00 CST 2018, time=2018-06-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327120, encodeId=b7f032e120d6, content=改革创新永远在路上, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Tue Jun 26 08:57:30 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326960, encodeId=373832696025, content=学习了.谢谢分享., beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Mon Jun 25 19:04:41 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326943, encodeId=fc1832694317, content=好吧., beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Mon Jun 25 18:29:02 CST 2018, time=2018-06-25, status=1, ipAttribution=)]
    2018-06-25 医者仁心5538

    好吧.

    0

相关资讯

人社部:全国开展按病种付费,不少于100个!

按病种付费又有了新消息!人社部推荐了130个病种,要求各地应确定不少于100个开展按病种付费。

定了!这些中医门诊按病种付费

5月22日,浙江省人社厅发布公告,就关于开展基层中医门诊常见病按病种支付方式改革向公众征求意见。

按病种付费 提升质量是灵魂

医疗保险按病种付费目录的推荐,是医疗保险付费方式改革的重要步骤,要把这项工作落实到位,需要处理好按病种付费与按服务质量付费之间的关系,进行包括医保支付标准在内的各项配套改革。

按病种付费将重创“中国神药”!

“按病种付费”是国内外证明行之有效的医保控费方式,其对应的一个学术范畴是DRGs(单病种付费体系)。

贵州改革医保支付方式 推行按病种付费

到2020年,医保支付方式改革将覆盖贵州所有医疗机构及医疗服务。

重磅发布!130病种打包付费,影响这些药......

有业内人士评论称,2018年,医药行业最大的事件就是按病种付费全面推行。